Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients

NCT06265259 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Circulatory Shock

Interventions

DRUG: Initiation of vasopressine as a first vasoconstrictive drug
DRUG: Initiation of noradrenaline as a first vasoconstrictive drug

Sponsor

University of Thessaly